NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 243 filers reported holding NEOGENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $187,686 | -69.7% | 15,259 | -60.4% | 0.06% | -67.8% |
| Q2 2023 | $619,852 | -25.5% | 38,572 | -19.3% | 0.17% | -35.8% |
| Q1 2023 | $832,390 | +412.4% | 47,811 | +171.9% | 0.27% | +316.9% |
| Q4 2022 | $162,448 | -13.1% | 17,581 | +14.0% | 0.06% | -37.5% |
| Q1 2022 | $187,000 | -63.1% | 15,421 | +46.9% | 0.10% | -67.4% |
| Q3 2021 | $507,000 | +126.3% | 10,500 | -10.5% | 0.32% | +56.4% |
| Q3 2019 | $224,000 | +16.7% | 11,727 | -23.2% | 0.20% | +100.0% |
| Q4 2018 | $192,000 | +12.3% | 15,260 | -28.4% | 0.10% | +22.9% |
| Q2 2016 | $171,000 | – | 21,300 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |